Cargando…
Effective Non-Viral Delivery of siRNA to Acute Myeloid Leukemia Cells with Lipid-Substituted Polyethylenimines
Use of small interfering RNA (siRNA) is a promising approach for AML treatment as the siRNA molecule can be designed to specifically target proteins that contribute to aberrant cell proliferation in this disease. However, a clinical-relevant means of delivering siRNA molecules must be developed, as...
Autores principales: | Landry, Breanne, Aliabadi, Hamidreza Montazeri, Samuel, Anuja, Gül-Uludağ, Hilal, Jiang, Xiaoyan, Kutsch, Olaf, Uludağ, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432090/ https://www.ncbi.nlm.nih.gov/pubmed/22952927 http://dx.doi.org/10.1371/journal.pone.0044197 |
Ejemplares similares
-
Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines
por: Parmar, Manoj B., et al.
Publicado: (2015) -
BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery
por: Yogasundaram, Haran, et al.
Publicado: (2012) -
Editorial: Current approaches to CRISPR/Cas9 delivery
por: Uludağ, Hasan, et al.
Publicado: (2022) -
Hydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics
por: Patil, Sushilkumar, et al.
Publicado: (2018) -
Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models
por: Zhu, Peican, et al.
Publicado: (2016)